NPI 1487661930: Open Payments
NPI 1487661930. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$114 in 6 payments from 3 companies in 2025. Trend: 2023 $426 · 2024 $0 · 2025 $114
Food & beverage: $114
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: ARISTADA, AUSTEDO XR, CAPLYTA.
